Seglentis approved for acute pain Roshni Dhar26 Oct 2021 4:44 PM ISTThe US Food and Drug Administration (FDA) has approved Seglentis a combination of celecoxib and tramadol hydrochloride for severe acute pain in...
Medical Bulletin 23/October/2021 Roshni Dhar23 Oct 2021 5:45 PM ISTHere are Top Medical stories of the dayA combination pill approved for severe acute pain in adults The US Food and Drug Administration (FDA) has...
Tramadol use linked to higher risk of mortality, compared to codeine: JAMA MD Editorial Team23 Oct 2021 10:45 AM ISTSpain: In a study conducted by Junqing Xie and team, it was found that a new tramadol prescription was significantly associated with a higher risk of...
FDA approves combination pill for severe acute pain in adults Dr Kartikeya Kohli20 Oct 2021 10:18 AM ISTThe US Food and Drug Administration (FDA) has approved Seglentis a combination of celecoxib and tramadol hydrochloride for severe acute pain in...
Punjab: Private Allopathic clinic run by Ayurvedic doctor sealed Revu suresh17 Oct 2021 9:30 AM ISTZirakpur: A private allopathic clinic allegedly run by an Ayurvedic doctor under the garb of MD (doctor of medicine) was sealed by the district...
Avenue Therapeutics gets USFDA Complete Response Letter for IV Tramadol Ruchika Sharma15 Jun 2021 10:00 AM ISTAvenue disagrees with the FDA's interpretation of the data in the NDA and intends to continue to pursue regulatory approval for IV tramadol.
CDSCO Declares 15 Drug Samples Including Levofloxacin, Paracetamol As Not Of Standard Quality MD Bureau23 Jan 2021 10:46 AM ISTNew Delhi: The apex drug regulatory body, Central Drugs Standard Organization (CDSCO) has flagged 15 drug samples as "Not of Standard Quality" after...
Cipla associate Avenue Therapeutics gets regulatory update for intravenous tramadol Farhat Nasim18 Dec 2020 6:23 PM ISTCipla said Avenue had requested this Type A meeting to address a CRL it received from the US health regulator regarding the New Drug Application (NDA)...
Avenue Therapeutics gets USFDA complete response letter for IV Tramadol Ruchika Sharma17 Oct 2020 9:00 AM ISTThe CRL stated that IV tramadol, intended to treat patients in acute pain who require an opioid, is not safe for the intended patient population.
Tramadol gets rejected by FDA owing to safety concerns Medha Baranwal15 Oct 2020 11:25 PM ISTUSA: The US Food and Drug Administration (FDA) has issued a complete response letter ("CRL") regarding the New Drug Application ("NDA")...
Tramadol use linked to increased Hip fracture risk Hina Zahid6 March 2020 7:00 PM ISTTramadol has been recommended as one of the first‐line or second‐line therapies for patients with chronic noncancer pain by several professional...
Study links Tramadol use to increased Hip fracture risk Hina Zahid5 Feb 2020 12:34 PM ISTOpioid treatment for chronic pain is a known risk factor for falls and/or fractures in elderly patients. Tramadol has a higher risk of fractures than...
